BackgroundCheck.run
Search For

Joel V Weinstock, 7755 Bakers Hill Rd, Weston, MA 02493

Known as:
Joel Vincent Weinstock Joel V Wienstock Joel A Wienstock Jorl V Weinstock Joel V Weinstrock Jeffrey Weinstock Jeff Weinstock Jeffrey Wienstock
Related to:
Moira E Lewis 72

Joel Weinstock Phones & Addresses

55 Bakers Hill Rd, Weston, MA 02493    781-8941311   

92 Penfro Dr, Iowa City, IA 52246    319-3542250   

Delray Beach, FL   

Carrollton, TX   

Beverly Hills, MI   

92 Penfro Dr, Iowa City, IA 52246    319-6215594   

Work

Company: Tufts Medical Center Gastroenterology Address: 800 Washington St Suite 233, Boston, MA 02111 Phones: 617-6365883 (Phone) 617-6364505 (Fax)

Education

School / High School: Wayne State University School Of Medicine 1973

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Gastroenterology, 1979
Get Report
Control this profile

Mentions for Joel V Weinstock

Career records & work history

Medicine Doctors

Joel Weinstock Photo 1

Dr. Joel V Weinstock, Boston MA - MD (Doctor of Medicine)

Specialties:
Gastroenterology
Address:
750 Washington St Suite 233, Boston, MA 02111
617-6368387 (Phone)
Tufts Medical Center Gastroenterology
800 Washington St Suite 233, Boston, MA 02111
617-6365883 (Phone) 617-6364505 (Fax)
Certifications:
Gastroenterology, 1979
Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Wayne State University School Of Medicine
Graduated: 1973
Medical School
University Hospital Of Mi
Graduated: 1973

Joel V. Weinstock

Specialties:
Gastroenterology
Work:
Pratt Medical Group IncTufts Medical Center Gastroenterology & Hepatology
800 Washington St STE 233, Boston, MA 02111
617-6365883 (phone) 617-6369292 (fax)
Site
Education:
Medical School
Wayne State University School of Medicine
Graduated: 1973
Procedures:
Colonoscopy, Sigmoidoscopy, Upper Gastrointestinal Endoscopy
Conditions:
Gastrointestinal Hemorrhage, Inflammatory Bowel Disease (IBD), Abdominal Hernia, Acute Pancreatitis, Alcohol Dependence, Anal Fissure, Anemia, Benign Polyps of the Colon, Celiac Disease, Cirrhosis, Constipation, Dermatitis, Disorders of Lipoid Metabolism, Diverticulitis, Diverticulosis, Esophagitis, Gastroesophageal Reflux Disease (GERD), Hemorrhoids, Hypertension (HTN), Irritable Bowel Syndrome (IBS), Malignant Neoplasm of Esophagus, Peptic Ulcer Disease, Venous Embolism and Thrombosis
Languages:
Chinese, English, Spanish
Description:
Dr. Weinstock graduated from the Wayne State University School of Medicine in 1973. He works in Boston, MA and specializes in Gastroenterology. Dr. Weinstock is affiliated with Tufts Medical Center.

Joel Weinstock resumes & CV records

Resumes

Joel Weinstock Photo 14

Direct Lender

Industry:
Real Estate
Work:
Yw Lending
Direct Lender Jw Realty & Associates
Real Estate Broker
Skills:
Strategic Planning, Direct Lending, Construction Loans, Sales, Negotiation, Loans, Management
Languages:
English
Joel Weinstock Photo 15

Joel Weinstock

Joel Weinstock Photo 16

Joel Weinstock

Publications & IP owners

Us Patents

Use Of Parasitic Biological Agents For Prevention And Control Of Autoimmune Diseases

US Patent:
7250173, Jul 31, 2007
Filed:
Feb 13, 2004
Appl. No.:
10/779249
Inventors:
Joel V. Weinstock - Iowa City IA, US
David E. Elliott - North Liberty IA, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A61K 39/00
A61K 39/38
A61K 39/002
A61K 39/005
A61K 39/008
US Classification:
4242651, 4242691, 4241841
Abstract:
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis and multiple sclerosis can be treated by the methods and compositions disclosed therein.

Use Of Parasitic Biological Agents For Prevention And Control Of Autoimmune Diseases

US Patent:
7833537, Nov 16, 2010
Filed:
Jul 30, 2007
Appl. No.:
11/888061
Inventors:
Joel V. Weinstock - Iowa City IA, US
David E. Elliott - Iowa City IA, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A61K 39/00
A61K 39/38
A61K 39/002
A01N 63/00
A01N 65/00
US Classification:
4242651, 4242691, 4241841, 424 931
Abstract:
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis and multiple sclerosis can be treated by the methods and compositions disclosed therein.

Use Of Parasitic Biological Agents For Prevention And Control Of Autoimmune Diseases

US Patent:
2003003, Feb 27, 2003
Filed:
Dec 11, 1998
Appl. No.:
09/209732
Inventors:
JOEL V. WEINSTOCK - IOWA CITY IA, US
DAVID E. ELLIOTT - IOWA CITY IA, US
Assignee:
PALMER AND DODGE
International Classification:
A61K039/02
US Classification:
424/234100
Abstract:
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis and multiple sclerosis can be treated by the methods and compositions disclosed therein.

Use Of Parasitic Biological Agents For Diseases Prevention And Control

US Patent:
2005011, Jun 2, 2005
Filed:
Nov 17, 2003
Appl. No.:
10/715659
Inventors:
Joel Weinstock - Iowa City IA, US
David Elliott - Iowa City IA, US
International Classification:
A61K039/05
G01N033/53
G01N033/569
US Classification:
435007220, 424245100
Abstract:
The invention relates to a method of screening a heminthic parasite preparation that affects a regulatory T cell function and a method of treating a disease by altering a regulatory T cell activity through the administration of a parasite preparation.

Treatments With Helminths

US Patent:
2010026, Oct 14, 2010
Filed:
Apr 10, 2008
Appl. No.:
12/595128
Inventors:
Joel Weinstock - Weston MA, US
Vincent B. Young - Ann Arbor MI, US
International Classification:
A61K 35/56
C12Q 1/18
A61P 3/04
US Classification:
424520, 435 32
Abstract:
The invention relates to a method of treating obesity or IBS in an individual by administering a physiologically acceptable composition comprising a helminthic parasite, or an active variant thereof, that is of a type and present in an amount sufficient to treat the individual for obesity or IBS. The invention is not limited to obesity and IBS and is further drawn to conditions of health in which the microbiota profile for a population of microbes found within an individual contributes to a pathological condition.

Use Of Parasitic Biological Agents For Diseases Prevention And Control

US Patent:
2010030, Dec 2, 2010
Filed:
Sep 19, 2008
Appl. No.:
12/234332
Inventors:
Joel V. Weinstock - Iowa City IA, US
David E. Elliott - Iowa City IA, US
Assignee:
University of Iowa, The Research Foundation - Iowa City IA
International Classification:
A61K 49/00
A61K 39/00
A61P 37/00
A61P 37/04
A61P 29/00
A61K 35/56
C12Q 1/02
US Classification:
424 91, 4242651, 424520, 435 29
Abstract:
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis, multiple sclerosis, autoimmune thyroiditis, allergic rhinitis, colon polyps/colon cancer and asthma can be treated by the methods and compositions disclosed therein.

Possible Relatives

Cynthia B Weinstock  David E Weinstock  Deborah J Weinstock  Daniel S Weinstock  Donna C Weinstock  Doris Weinstock  Earl Weinstock  Joel N Johnson  Joel Standefer  Joel S Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.